Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: N Engl J Med. 2020 Apr 2;382(14):1320–1330. doi: 10.1056/NEJMoa1910215

Table 2.

Estimates of First Recurrences, Hospitalizations, and In-Hospital Deaths Associated with CDI, According to Epidemiologic Class, at 10 U.S. Emerging Infections Program Sites, 2011–2017.*

Surveillance Year Estimated First Recurrences Estimated Hospitalizations Estimated In-Hospital Deaths
Community-Associated CDI Health Care-Associated CDI Community-Associated CDI Health Care-Associated CDI Community-Associated CDI Health Care-Associated CDI
2011 678 1959 1691 6145 159 889
2012 703 1848 2130 6527 161 571
2013 879 1665 2259 6398 202 581
2014 843 1690 2320 6537 142 670
2015 1066 1740 2633 6643 198 812
2016 1092 1380 2740 6024 190 750
2017 967 1221 2505 5483 164 573
*

The frequency of cases was weighted to account for sampling in two of the Emerging Infections Program sites (Colorado and Georgia) and sampling of health care–associated CDI cases. Recurrence refers to the first recurrent episode, defined as a positive stool specimen within 2 to 8 weeks after the initial positive test. Hospitalization includes admission on the day of or in the 6 calendar days after diagnosis of CDI. In-hospital deaths refer to deaths that occurred during hospitalization.